Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma
Abstract The cancer “omics” reveal many clinically relevant alterations that are transforming the molecular characterization of glioblastomas. However, many of these findings are not yet translated into clinical practice due, in part, to the lack of non-invasive biomarkers and the limitations impose...
Main Authors: | Eduardo Ruiz-López, Ivana Jovčevska, Ruth González-Gómez, Héctor Tejero, Fátima Al-Shahrour, Serge Muyldermans, Alberto J. Schuhmacher |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-27161-3 |
Similar Items
-
Sonication is a suitable method for loading nanobody into glioblastoma small extracellular vesicles
by: Sara Colja, et al.
Published: (2023-05-01) -
Immunotargeting of Cancer Stem Cells
by: Ayse Sedef Köseer, et al.
Published: (2023-03-01) -
TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers.
by: Ivana Jovčevska, et al.
Published: (2014-01-01) -
TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion
by: Andrej Porčnik, et al.
Published: (2021-08-01) -
Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo
by: Alja Zottel, et al.
Published: (2023-01-01)